Cutting edge proton beam therapy is no better than intensity-modulated radiotherapy for treating people with head and neck cancer, according to new research. The nationwide TORPEdO trial funded by ...

On average, we advertise around 15-20 fully-funded PhD opportunities each year. This year we will be advertising our new projects and accepting applications from Wednesday 8th October 2025. Projects ...

Need to find a specific expert or member of a research group or division? Just search by role, division, name or browse our researchers A-Z.

We have partnered with Make a Will Online to offer you the opportunity to create a simple Will digitally - at no cost to you. These Wills are checked by a qualified solicitor, providing you with an ...

Targeted protein degradation (TPD) has transformed cancer drug discovery by enabling removal of harmful proteins using small molecule degraders. PROTACs (Proteolysis Targeting Chimeras) and MGDs ...

The Institute of Cancer Research, London, strongly welcomes the decision by NICE to recommend the targeted breast cancer drug, capivasertib, in combination with fulvestrant, for treating the most ...

Scientists have discovered a key protein that could be targeted with a drug to treat the most common and aggressive form of pancreatic cancer. The findings, published in Nature, show that blocking the ...

We are a world-leading cancer research institute, a charity, and a member institution of the University of London. Public donations and clinical partnerships are helping us to make the discoveries ...

The Centre for Children and Young People's Cancer (CCC) serves as the focal point of basic, translational and clinical ...

The ICR and The Royal Marsden have teamed up with PureGym to encourage men with advanced prostate cancer to be more active. The initiative will see PureGym offer a free one-year gym membership for ...